BOS GLOBAL Holdings NL has issued an update on its operations.
BOS has appointed its wholly-owned subsidiary BOS Distributions Pty as the licensee for the purposes of promoting, marketing, distributing, reproducing, supplying and publishing the Kronologica and Meetingly products to third party end users with effect from 12 Septembe, replacing the previous licensee Hostisme Pty Ltd (a 50:50 JV company).
BOS has also announced it has appointed Dr Luke Strotz as chief scientific adviser to BOS GLOBAL Holdings NL.
Strotz's field of study in Bio Science will offer a unique perspective towards the collection of workplace data as well as valuable insights into the dynamics of workplace communities.
Strotz will advise the BOS-360 Work Patterns team on the development of a purpose built taxonomy (a system for classifying data). This taxonomy will become the foundation of the BOS360 Platform as a Service (PaaS).
1,075,200 fully paid ordinary shares have been allotted to Capresi Consolidated Limited for the provision of advisory services in relation to the company's readmission to AIM. Application has also been made for these shares to be admitted to trading on AIM on or around 21 September 2016.
Following admission of the shares, BOS will have 51,075,198 fully paid ordinary shares in issue.
The company has also granted 500,000 warrants to RFC Ambrian Limited under the terms of their engagement agreement. The warrants expire on 30 August 2021 and have an exercise price of 10.4 pence.
Finally, shareholders are advised that the new corporate website for BOS is now live. The address for the new website is www.bosglobal.com.